Abacavir

規格

136470-78-5CAS番号

620-487-9EC番号

[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanolIUPAC名

C14H18N6O化学式

286.33 g/mol分子量

abacavir; 136470-78-5; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol; Avacavir; WR2TIP26VS; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-; DTXSID4046444; CHEBI:421707; NSC-742406; [(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl]methanol; [(1s,4r)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]-1-cyclopent-2-enyl]methanol; {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol; 2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S-cis)-; (-)-CIS-4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL; (1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol; 2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S,4R)-; abacavirum; ((1S,4R)-4-(2-amino-6-(cyclopropylamino)purin-9-yl)-1-cyclopent-2-enyl)methanol; ((1S-cis)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol; (+)-abacavir sulfate; RefChem:551202; (1R,4S)-abacavir sulfate; J05AF06; DTXCID601478426; 620-487-9; Ziagen; Abacavir [INN]; 1592U89; Abacavir (INN); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; MFCD00903850; ABC; Abacavir (1.0 mg/mL in Methanol); (+/-)-Abacavir; Abacavir [INN:BAN]; UNII-WR2TIP26VS; NSC742406; Ziagen (TM)(*Succinate salt*); NCGC00164560-01; Abacavir; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S-cis)-; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; 1592U89; ABC; Abacavir (Standard); ABACAVIR [MI]; ABACAVIR [VANDF]; AVACAVIR [VANDF]; ABACAVIR [MART.]; ABACAVIR [WHO-DD]; Epitope ID:137341; ABACAVIR [EMA EPAR]; CHEMBL1380; SCHEMBL38632; Abacavir - Bio-X trade mark; MLS006010117; orb1309177; SCHEMBL7795337; SCHEMBL23391283; GTPL11152; Abacavir (1 mg/mL in Methanol); MCGSCOLBFJQGHM-SCZZXKLOSA-N; GLXC-06957; SRCA-00004; MSK11262; BDBM50366816; EBC-12628; HY-17423R; AKOS024464970; AC-1299; CCG-267342; CS-1354; DB01048; DT-0030; NA10018; NSC 742406; (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; NCGC00164560-02; NCGC00164560-05; NCGC00164560-17; BA166801; HY-17423; SMR004701251; SY009678; A0401; A2694; NS00007385; T1267; C07624; D07057; EN300-258000; AB01566826_01; F463835; Q304330; BRD-K17443395-065-01-4; (+/-)-cis-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol別名